August 2011 Issue of MMM
Just as we are going to press with this August print issue, the FDA has issued a set of draft guidelines for mobile medical apps.
Outside the US, bespoke tools and resources that doctors can use at the point of care through a mobile device are still somewhat rare. An ...
Does the battle for social supremacy being waged by Google, Facebook and Bing make this medium more or less viable for pharma marketers?
Fred's a really nice managed care guy. But does he have the right stuff to get your brand the preferred nod? Kevin McDermott explains how ...
Big is not necessarily bad, says Pfizer PR supremo Sally Susman. "Big can be a force for good."
Newly launched products break ground in clearing life-threatening viruses and stanching stubborn infections. But that's only half the battle
Over the last few months, I've been thinking a lot about trends in pharmaceutical marketing research.
One out of five Americans still smokes, and smoking leads to cancer and heart disease.
FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.
On July 1, GlaxoSmithKline embarked upon a new phase in plans to overhaul its incentive compensation package, pegging sales rep pay to a combination of ...
Specialty drug group Par Pharmaceutical Companies has announced the restructuring of its branded division, Strativa, by way of axing 100 sales operations staff from the ...
Featuring news about DMD, PDR Network and Delta Point
Med Ed Report
A recently passed report by the AMA's Council on Ethical and Judicial Affairs (CEJA) won't have a significant effect on commercial funding for CME, pharma ...
Two restrictive Massachusetts statutes, one barring pharmaceutical gifts to doctors and another drug discount coupons for consumers, remained unchanged in the state's recently passed budget ...
Following a review, Harvard Medical School and the affiliated Massachusetts General Hospital levied sanctions against three psychiatrists accused by Sen. Charles Grassley (R-IA) of breaking ...
Featuring news about European Federation of Pharmaceutical Industries and Associations, CME Coalition, DIME and Haymarket Medical
Quadrant HealthCom Inc. (QHI), the Parsippany, NJ-based multimedia communications company specializing in healthcare, has announced the appointment of Mary Holeton to the position of president ...
Elsevier has launched an international online journal, in association with the Australian Society for Parasitology, titled the International Journal for Parasitology: Drugs and Drug Resistance.
Featuring news about Everyday Health, American Heart Association, Quadrant HealthCom and Elsevier
Google tried one-upping its rival when it released a Facebook-esque package of social media features known as Google+. Is this a game changer, and what ...
WEGO Health is launching an ad-supported online video network, dubbed WEGOHealth.tv, that will feature "conversation-style videos" featuring its medical subject matter expert "health activists," each ...
In continuing to roll out its Facebook-like social media-based offerings, Google has launched a beta version of a new service called Google+, which strives to ...
Featuring news about Sermo, DDMAC, Cephalon and Alzheimer's Association
An implicit objective of all DTC campaigns is to empower patients with information to speak to their HCP about a treatment or specific drug.
Everyday Health is planting its flag in network television with an ABC show that is being produced by The Biggest Loser creator Mark Koops.
Merck is launching a chronic hepatitis C awareness campaign featuring rocker and hepatitis C sufferer Gregg Allman, whose Allman Brothers Band headlined a benefit concert ...
Uloric maker Takeda and Men's Health Network recruited a pair of racing world rivals to hype a gout awareness campaign, dubbed "Gout Pit Stop."
AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.
Featuring news about Novo Nordisk, Prescription Medicines Code of Practice Authority, Bayer HealthCare and Merck
The US Supreme Court ordered a lower court to reappraise its ruling upholding a Maine data-mining law, after striking down a similar statute in Vermont ...
Wolters Kluwer Pharma Solutions appointed Bob Jansen and Michelle Woker as co-presidents of its analytics business.
LBi, a big European indie digital agency network, is opening up a healthcare marketing shop in the US, seeing opportunity in Publicis' increasing domination of ...
Interpublic Group promoted Matt Lane, co-founder and managing director of NeON, to a position at the holding company level.
Featuring news about Rosetta Wishbone, inVentiv, Chandler Chicco and Chamberlain Communications and McCann Healthcare Worldwide
A reported FDA plan, secretly developed to enforce the rarely used 36-year-old "strict liability" Park Doctrine against Forest Laboratories CEO Howard Solomon, reflects a poorly ...
FDA commissioner Margaret Hamburg says the agency's priorities for the next five years will be advancing regulatory science and innovation.
While federal web portals earned an average score of 75 on a 100-point satisfaction scale in a ForeSee Results survey of customers, FDA's main website ...
The term "iceberg" may seem overly dramatic when considering the impact of e-prescribing on the pharmaceutical industry, however, it is an appropriate analogy given the ...
While doctors and nurses remain the first choice for most people with health concerns, the internet is making a significant impact on patients' healthcare decisions.
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
- Walgreen to vote on merger with Alliance Boots
- PBM deal on new hep.-C cocktail highlights drugmaker tolerance for discounts
- GSK shingles vax shaping up to compete with Merck's
- Five things for pharma marketers to know: Monday, December 22
- Five Big Shifts in Policy and Technology That Marketers Should Worry about in 2015